Video

Treatment Options for Patients with Epilepsy Due to Tuberous Sclerosis Complex

Conference|AES Annual Meeting - American Epilepsy Society Annual Meeting

Elizabeth Thiele, MD, PhD, pediatric neurologist/epileptologist, discusses treatment options for patients with epilepsy due to tuberous sclerosis complex.

Elizabeth Thiele, MD, PhD, pediatric neurologist/epileptologist, discusses treatment options for patients with epilepsy due to tuberous sclerosis complex.

Related Videos
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: Dr_Microbe | stock.adobe.com
Related Content
Diet plan, menu or program, tape measure, water, dumbbells and diet food of fresh fruits on white background, weight loss and detox concept, top view - Image credit: anatoliycherkas | stock.adobe.com
June 4th 2025

Researchers Identify Sex-Based Differences In Diet and Metabolism

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Molecular biologist holding blood sample for EGFR mutation test for the diagnosis of lung disease. Epidermal Growth Factor Receptor.
June 4th 2025

Neoadjuvant Osimertinib With or Without Chemotherapy Improves Response in Resectable EGFRm NSCLC

Luke Halpern, Assistant Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
3D visualization of white blood cells | Image Credit: © stockdevil - stock.adobe.com
June 4th 2025

Fixed-Duration Ibrutinib Plus Venetoclax Shows Long-Term Efficacy in First-Line CLL/SLL Treatment

Alexandra Gerlach, Associate Editor
Chemotherapy IV drip -- Image credit: sweetlemontea | stock.adobe.com
June 4th 2025

ASCO 2025: Adding Carboplatin Did Not Result in Statistically Significant Improvements in Patients With TNBC

Gillian McGovern, Associate Editor